Stem Cell Theranostics
Signal active
Organization
Contact Information
Overview
Stem Cell Theranostics (SCT) is a biotechnology company dedicated to accelerating therapeutic discovery and enabling personalized medicine using patient-derived cell models.
About
Industries
Biotechnology, Health Care, Medical, Therapeutics, Precision Medicine
Founded
2013
Employees
11-50
Headquarters locations
Redwood City, California, United States, North America
Social
Profile Resume
Stem Cell Theranostics headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Therapeutics, Precision Medicine sector. The company focuses on Biotechnology and has secured $226.0M in funding across 40 round(s). With a team of 11-50 employees, Stem Cell Theranostics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Stem Cell Theranostics, raised $5.5M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
1
Lead Investors
0
Total Funding Amount
$5.7M
Details
1
Stem Cell Theranostics has raised a total of $5.7M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2014 | Early Stage Venture | 5.5M |
Investors
Stem Cell Theranostics is funded by 4 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Stem Cell Theranostics | - | FUNDING ROUND - Stem Cell Theranostics | 150.0K |
| National Science Foundation | - | FUNDING ROUND - National Science Foundation | 150.0K |
| Stem Cell Theranostics | - | FUNDING ROUND - Stem Cell Theranostics | 5.5M |
| Bill Marcus | - | FUNDING ROUND - Bill Marcus | 5.5M |